Disseminated colon cancer with severe peripheral blood eosinophilia and elevated serum levels of interleukine-2, interleukine-3, interleukine-5, and GM-CSF.
Anagnostopoulos
George K
GK
Sakorafas
George H
GH
Kostopoulos
Panagiotis
P
Margantinis
George
G
Tsiakos
Stavros
S
Terpos
Evaggelos
E
Pavlakis
George
G
Fortun
Paul
P
Arvanitidis
Dimitrios
D
D000230:Adenocarcinoma / Q000556:secondary; D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D002430:Cecal Neoplasms / Q000473:pathology; D003110:Colonic Neoplasms / Q000150:complications / Q000188:drug therapy / Q000473:pathology*; D003937:Diagnosis, Differential; D004802:Eosinophilia / Q000097:blood* / Q000175:diagnosis / Q000209:etiology; D005260:Female; D016178:Granulocyte-Macrophage Colony-Stimulating Factor / Q000097:blood*; D006801:Humans; D007376:Interleukin-2 / Q000097:blood*; D007377:Interleukin-3 / Q000097:blood*; D015848:Interleukin-5 / Q000097:blood*; D008113:Liver Neoplasms / Q000556:secondary; D011379:Prognosis
D007376:Interleukin-2; D007377:Interleukin-3; D015848:Interleukin-5; D016178:Granulocyte-Macrophage Colony-Stimulating Factor